News Archive - Specialised Therapeutics - Page 5

Professor Arlene Chan discusses interim results from the Oncotype DX RxPONDER study, presented at the 2020 San Antonio Breast Cancer Symposium. Click on the video banner above to watch the video.

Specialised Therapeutics Australia (STA) welcomes the opportunity to provide comments on the introduction of new measures to improve TGA transparency. STA was co-founded in 2008, with a commitment to commercialising specialist therapies and technologies that meet the unmet medical needs of all patients in its regions. Underpinning this endeavour is a foundation of innovation, which must be protected by regulatory transparency.

Karen Lurati was in her late forties, juggling a busy career and family when she noticed she was steadily gaining weight. Because she was also experiencing other symptoms like tiredness and hot flushes, she put it down to menopause. It was only when she felt an increased heaviness, or pressure on her pelvic floor, that

Many patients are “scared of being a guinea pig” but the reality is that they’re likely to have better outcomes if they choose to take part in a clinical trial.  So says Dr Susie Bae, who specialises in both sarcoma and breast cancers. Her advice to patients is always to participate in a trial if

Immunotherapy drugs used as single agent therapies are so far showing little effect in treating sarcomas, according to an Adelaide-based sarcoma specialist, Dr Ganessan Kichenadasse. He says that while there have been some positive steps forward in treating sarcomas in the past 20 years, there is much more to be achieved. Dr Kichenadasse predicts the

The following article features in Issue One of the ST BREAST magazine. BEFORE, DURING AND AFTER BREAST CANCER Good nutrition can impact breast cancer treatment tolerance and recovery,1 as well as reduce the risk of recurrence1,2 and improve long-term health, according to Accredited Practising Dietitians (APDs) Lauren Atkins and Elise Den. The pair, who co-founded OnCore Nutrition

The following article features in Issue One of the ST BREAST magazine. Dr Lisa Beatty is a Senior Clinical Psychologist and Cancer Council South Australia Senior Research Fellow at the Flinders Centre for Innovation in Cancer. She has  expertise in psycho-oncology – the scientific exploration of the psychological impact and treatment of cancer.   BETWEEN

The following article features in Issue One of the ST BREAST magazine.   Within 72 hours of her breast cancer diagnosis four years ago, Ally Fairbairn found herself in the offices of Melbourne breast cancer surgeon Chantel Thornton. She was pragmatic, telling the surgeon to just “do whatever you have to do and tell me

Neurosurgeon Professor Kate Drummond says all brain cancer patients want more time. “There is always a wedding, a baby, an event or someone that needs to be cared for,” she says. But with the most serious form of brain cancer, glioblastoma multiforme or GBM, time runs out too quickly – despite the greatest efforts of

In Brain Tumour Awareness Month, we are recognising passionate people who are making a difference in brain cancer. Vanessa van den Berg is a senior ST brand manager, responsible for marketing several products in oncology and haematology. But, she has a very personal reason for making a difference in brain cancer.   “I’m a strong